Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules

Go back to Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules
(NASDAQ: ETON) Delayed: 49.30 -0.89 (1.77%)
Previous Close $50.19    52 Week High $ 
Open $50.93    52 Week Low $ 
Day High $50.93    P/E N/A 
Day Low $48.66    EPS $ 
Volume 310,031